James F. Young, Director at NOVAVAX INC (NVAX), sold 7,500 shares at $14.09 ($106K) on 2024-06-21, disclosed to the SEC on 2024-06-25.
Seasonal sale ($106k) by Director — this insider has traded NVAX in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| NVAX | SELL | 2022-04-04 | $1.8M | — | Filing → |
| NVAX | SELL | 2022-01-04 | $541K | — | Filing → |
| NVAX | SELL | 2021-03-25 | $4.6M | — | Filing → |